Systemic immune-inflammation index to predict survival in patients with metastatic urothelial carcinoma treated with second-line vinflunine.

Patrik Palacka,Jana Katolická,Tana Albertova,Katarina Rejlekova,Jana Obertova,Matej Hrncar,Michal Chovanec,Jan Slopovsky,Michal Mego

Systemic immune-inflammation index to predict survival in patients with metastatic urothelial carcinoma treated with second-line vinflunine.

2020

Patrik Palacka
Jana Katolická
Tana Albertova
Katarina Rejlekova
Jana Obertova
Matej Hrncar
Michal Chovanec
Jan Slopovsky
Michal Mego

e17019Background: Based on our previous study, the systemic immune-inflammation index (SII) is a prognostic factor in patients with metastatic urothelial cancer (MUC) treated with platinum-based fi...

Keywords:

Internal medicine
Metastatic Urothelial Carcinoma
Oncology
Vinflunine
Medicine
second line
immune inflammation
Pathology
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations